Baijin Life Science Holdings's quarterly market cap
declined
from Sep. 2024 ($47.55 Mil) to Mar. 2025 ($46.34 Mil) but then
increased
from Mar. 2025 ($46.34 Mil) to Sep. 2025 ($61.79 Mil).
Baijin Life Science Holdings's annual market cap
increased
from Mar. 2023 ($38.36 Mil) to Mar. 2024 ($50.94 Mil) but then
declined
from Mar. 2024 ($50.94 Mil) to Mar. 2025 ($46.34 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Baijin Life Science Holdings's Enterprise Value for Today is $152.00 Mil.
Baijin Life Science Holdings (OTCPK:MNNGF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Baijin Life Science Holdings Market Cap Related Terms
Baijin Life Science Holdings Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Luxury Goods subindustry, Baijin Life Science Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Baijin Life Science Holdings Market Cap vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Baijin Life Science Holdings's Market Cap distribution charts can be found below:
* The bar in red indicates where Baijin Life Science Holdings's Market Cap falls into.
Baijin Life Science Holdings Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Baijin Life Science Holdings (MNNGF) has a Market Cap of $146.27 Mil as of Jun. 28, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Baijin Life Science Holdings and its competitors. According to the industry distribution chart, Baijin Life Science Holdings ranks #568 out of 1137 companies in the Retail - Cyclical industry, placing it in the top 50%.
Is Baijin Life Science Holdings' Market Cap too high?
Baijin Life Science Holdings' current Market Cap is $146.27 Mil. The Retail - Cyclical industry median Market Cap is 144.25. Baijin Life Science Holdings' value of $146.27 Mil is 1.4% above this industry median. Based on the distribution chart, Baijin Life Science Holdings ranks #568 out of 1137 companies in the Retail - Cyclical industry, which is above the industry midpoint. Overall, Baijin Life Science Holdings has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Baijin Life Science Holdings' Market Cap compare to TPR?
According to the Retail - Cyclical industry distribution chart, Baijin Life Science Holdings ranks #568 out of 1137 companies for Market Cap. This puts Baijin Life Science Holdings in the upper half of its industry. The industry median Market Cap is 144.25. Baijin Life Science Holdings' value of $146.27 Mil is 1.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Retail - Cyclical company?
The median Market Cap among Retail - Cyclical companies is 144.25, based on 1,137 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Baijin Life Science Holdings's current Market Cap of $146.27 Mil is 1.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Baijin Life Science Holdings and its competitors. For the Retail - Cyclical industry, the median Market Cap is 144.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Baijin Life Science Holdings's current Market Cap is $146.27 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baijin Life Science Holdings stock overvalued right now?
Baijin Life Science Holdings (MNNGF) has a current Market Cap of $146.27 Mil. The stock's GF Value™ is $0.04, compared to a current price of $0.08 — trading 87.5% above its estimated fair value. The current Market Cap is $146.27 Mil and 1.4% above the Retail - Cyclical industry median of 144.25. Baijin Life Science Holdings' overall GF Score™ is 34/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Baijin Life Science Holdings (MNNGF), the current Market Cap is $146.27 Mil as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Baijin Life Science Holdings (MNNGF) Overvalued in 2026?
Based on GuruFocus' analysis, Baijin Life Science Holdings stock appears to be overvalued.
The current stock price of $0.08 is trading 87.5% above its estimated GF Value™ of $0.04.
Key valuation signals for MNNGF:
Market Cap: $146.27 Mil
GF Value™: $0.04 vs. price of $0.08 (87.5% above fair value)
Industry Position: 1.4% above the Retail - Cyclical median (#568 of 1137)
No single metric tells the full story. See the MNNGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company has three business segment: jewelry business segment; strategic investment segment; and skincare business segment. The majority of revenue is coming from jewelry business segment.
34GF Score
Get the complete analysis for MNNGF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MNNGF has been successfully added to your 
